Matrixx Initiatives gives Zicam a makeover with design firm Beardwood&Co
NEW YORK — Matrixx Initiatives partnered with design firm Beardwood&Co on the redesign of Zicam Cold Remedy, which was unveiled Wednesday.
“We helped define [the pre-cold] segment,” noted Julia Beardwood, Beardwood&Co principal. “But, to be successful, we had to help consumers quickly sort through this myriad of products in the cold aisle and understand what Zicam is and when to take it.”
To help educate consumers the packaging features a Pre-Cold seal in the shape of a bulls-eye as a unifying element that communicates preparedness and reassurance. The main benefit statement: “Reduces the Duration of a Cold” is prominently displayed under the bulls-eye. Zicam’s equities: the bold orange color, and blue on white brand identity were retained and enhanced for a more efficacious and modern feel, Beardwood noted.
“The Pre-Cold seal is a big advantage for our brand,” commented Leslie Molloy, SVP marketing, Zicam. “It positions us as leaders in this category with a strong central unifying element that has badge value for consumers and empowers them to do something when they feel the first signs of a cold. We are extending this element across all our marketing platforms including online, in-store displays and our advertising campaign.”
The Zicam product line includes 15 sku’s including Rapidmelt tablets, chewables, liquid lozenges, crystals packets and oral mist. The redesigned packages are currently rolling out nationwide, the company stated.
Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.
CDC: Effectiveness of flu vaccine in seniors only 9%
ATLANTA — This year’s triumvirate influenza vaccine was less effective in seniors as compared to the general population, according to the Centers for Disease Control and Prevention’s "Morbidity and Mortality Weekly Report" published Friday. Overall effectiveness of the vaccine was 56%, similar to an earlier interim estimate of 62%.
The adjusted, age-stratified vaccine effectiveness point estimates were 58% for children, 46% for adults younger than 50, 50% for men and women between the ages of 50 years and 64 years and 9% for seniors.
"These adjusted vaccine effectiveness estimates indicate that vaccination with the 2012–13 influenza season vaccine reduced the risk for outpatient medical visits resulting from influenza by approximately one half to two thirds for most persons, although [effectiveness] was lower and not statistically significant among older adults," the report read.
For the complete Feb. 22 MMWR issue, click here.
Rise-N-Shine highlights Wake Up on Time energy supplement
SPARTA TOWNSHIP, N.J. — Rise-N-Shine recently highlighted its Wake Up on Time supplement formulated to help night owls transform into morning people. Taken right before bed, Wake Up on Time starts to work six to eight hours later by releasing energy supplements for an alert, refreshed feeling.
“It’s more than a vitamin; it’s time in a bottle because, instead of hitting the snooze button over and over again, our product allows you bounce out of bed, ready to go,” Cathy Beggan, founder of Rise-N-Shine stated.
Wake Up On Time is a proprietary blend of B vitamins, amino acids, guarana seed extract and siberian ginseng that are geared to address the psychological and physical reasons why people have trouble getting out of bed in the morning.